About the position
Janssen Biotech, Inc., a member of Johnson & Johnson's Family of Companies, is recruiting for a Senior Financial Analyst- US Oncology - GU position located in Horsham, PA. The position will support the Oncology commercial franchise within Janssen Biotech, Inc. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world's most pressing healthcare challenges. Within the US Oncology business, our mission is to redefine cancer care by delivering outstanding and accessible therapeutic solutions that prolong and improve patients' lives.
Responsibilities
- Provide day-to-day financial leadership to the Oncology team focusing on the GU franchise (specifically ERLEADA, AKEEGA & TAR-200 brands) strategic priorities to drive growth as well as providing strategic support to brand marketing expenses (BMEs).
- Act as the go-to finance partner for GU Franchise cross-functional partners.
- Develop and shape GU Franchise sales and strategic investment forecasts, track sales and investments throughout the year, and assess impacts from competitive dynamics and market events.
- Influence cross-functional partners regarding investment decisions to drive value and deliver results.
- Provide launch support for TAR-200 to ensure a flawless launch execution.
- Correlate sales performance to brand strategy and market factors (demand trends, competitive intelligence, policy, data releases).
- Own forecasting/Integrated Business Planning cycles and quarterly close activities (including the Investor Relations package) for the GU franchise, ensuring financial and business compliance requirements are met.
- Own ad-hoc analyses and develop executive framing, with opportunities to present directly to Solid Tumor president and other senior leadership.
- Identify process improvements and provide recommendations on key focus areas.
